Vitamin D as an adjuvant in melanoma therapy.

Slominski, Andrzej T; Brozyna, Anna; Jozwicki, Wojciech; Tuckey, Robert C

Slominski, Andrzej T; Brozyna, Anna; Jozwicki, Wojciech; Tuckey, Robert C.

Afiliación

Slominski AT; Department of Pathology & Laboratory Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA ; Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Brozyna A; Department of Tumor Pathology & Pathomorphology, Oncology Center - Prof. Franciszek Lukaszczyk Memorial Hospital, The Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Bydgoszcz, Poland.
Jozwicki W; Department of Tumor Pathology & Pathomorphology, Oncology Center - Prof. Franciszek Lukaszczyk Memorial Hospital, The Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Bydgoszcz, Poland.
Tuckey RC; School of Chemistry & Biochemistry, the University of Western Australia, Crawley, Australia.

Melanoma Manag ; 2(1): 1-4, 2015 Jan 01.

Article en En | MEDLINE | ID: mdl-26052430

Palabras clave

CYP11A1; CYP27B1; adjuvant therapy; melanoma; metabolism; vitamin D; vitamin D receptor

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Melanoma Manag Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google